Overview

The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients

Status:
Completed

Trial end date:
1994-11-01

Target enrollment:

Participant gender:

Summary

To determine whether clarithromycin is safe and effective in preventing disseminated Mycobacterium avium Complex in HIV-infected patients with CD4 counts <= 100 cells/mm3.

Phase:

N/A

Details

Lead Sponsor:

Abbott

Treatments:

Clarithromycin